The enrichment in IFN-alpha/gamma signature, which is associated with the expression of the myeloid CEBPB factor in P4’s HSCs, closely resembles the changes that we have described previously in patients with CGD in a very severe, chronic inflammatory context24. Here, CEBPB is linked to chronic granulomatous disease.